Efracea
Images for illustrative purposes only
Efracea is a modified-release oral treatment containing 40mg of the active ingredient doxycycline monohydrate, specifically formulated to reduce the inflammatory papules and pustules caused by facial rosacea in adult patients.
- Targets inflammatory lesions, red bumps, and pimples specifically associated with facial rosacea
- Contains low-dose doxycycline to reduce skin inflammation without standard antibiotic resistance risks
- Simple once-a-day modified-release capsule designed for steady absorption and ease of use
- Available through a secure online consultation with registered UK prescribers and discreet home delivery
In Stock
Discreet Packaging
Prescription included
Quick & Easy